American Heart Association Awards $15 Million to Study Women's Cardiovascular-Kidney-Metabolic Health
The American Heart Association is funding groundbreaking research to understand how unique risk factors impact women's cardiovascular and kidney diseases. Three research centers will investigate critical aspects of cardiovascular-kidney-metabolic syndrome across different life stages.
The American Heart Association has awarded $15 million to three research teams to investigate cardiovascular-kidney-metabolic (CKM) syndrome in women, targeting a critical gap in medical understanding. Researchers from Augusta University, Massachusetts General Hospital, and The Ohio State University will explore why women experience distinct health risks across different life stages.
Approximately one in three U.S. adults has at least three components of CKM syndrome, which includes high blood pressure, abnormal cholesterol, high blood glucose, impaired kidney function, and excess body weight. Women have historically been underrepresented in clinical research, leading to limited understanding of how these conditions uniquely affect them.
Each research center will conduct multiple projects examining different aspects of women's health. Augusta University will study obesity's lifelong effects, Massachusetts General Hospital will investigate pregnancy's impact on future health risks, and The Ohio State University will develop community-based interventions targeting women's cardiovascular health.
The research aims to develop targeted preventive strategies and therapeutic approaches that account for biological differences and life cycle variations. By focusing on women's specific health experiences, these studies could significantly improve medical understanding and treatment of cardiovascular and kidney diseases.
This initiative represents a crucial step toward more personalized and comprehensive healthcare, potentially transforming how medical professionals approach women's health risks and interventions.